Autres langues Hangzhou Tigermed Consulting Co., Ltd

Actions

300347

CNE100001KV8

Cours en clôture Shenzhen S.E. Autres places de cotation 00:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
48,6 ^CNY	-0,37%		-4,37%	-11,59%

18/06	Hangzhou Tigermed Consulting Co. annonce des changements au sein de sa direction	CI
14/06	Tigermed Consulting assure que ses activités se déroulent normalement malgré les fluctuations du cours de l'action	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes	18/06
Tigermed Consulting Assures Normal Operations Amid Share Price Fluctuations	14/06
Hangzhou Tigermed Consulting Co., Ltd commences an Equity Buyback Plan for CNY 1,000 million worth of its shares, under the authorization approved on April 30, 2024.	23/05
Hangzhou Tigermed Consulting’s Profit Down 59% in Q1	25/04
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024	25/04
Borse Cina : chiudono miste, male Shanghai -0,7%, bene Hong Kong +1,92%	23/04
Tigermed Consulting's Profit, Revenue Climb in 2023	29/03
Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 18 July 2024	28/03
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Hangzhou Tigermed Consulting Co., Ltd Announces Executive Changes	21/03
China Healthcare Stocks Rally on Hopes for Government Support	14/03
China stocks steady, helped by biotech rally; Wuxi Apptec drags Hong Kong shares	14/03
Hangzhou Tigermed Consulting Plans Up to 1 Billion Yuan Share Repurchase; Shares Jump 4%	07/02
Hangzhou Tigermed Consulting Co., Ltd announces an Equity Buyback for CNY 1,000 million worth of its shares.	06/02
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.	06/02
Hangzhou Tigermed Consulting Co., Ltd authorizes a Buyback Plan.	06/02
Hangzhou Tigermed Consulting's Profit Up 19% in Q3	27/10/23
Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Tigermed Reports 2023 Interim Results	28/08/23
Tigermed Consulting's Profit Jumps 16.5% in H1	28/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hangzhou Tigermed Consulting Co., Ltd

Actions

300347

CNE100001KV8

Autres langues

Filtres